These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 28672205)
1. Pep-1 peptide-functionalized liposome to enhance the anticancer efficacy of cilengitide in glioma treatment. Jiao Z; Li Y; Pang H; Zheng Y; Zhao Y Colloids Surf B Biointerfaces; 2017 Oct; 158():68-75. PubMed ID: 28672205 [TBL] [Abstract][Full Text] [Related]
2. Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation. Kang MJ; Park SH; Kang MH; Park MJ; Choi YW Int J Nanomedicine; 2013; 8():1155-65. PubMed ID: 23515421 [TBL] [Abstract][Full Text] [Related]
3. Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis. Wang B; Lv L; Wang Z; Zhao Y; Wu L; Fang X; Xu Q; Xin H Biomaterials; 2014 Jul; 35(22):5897-907. PubMed ID: 24743033 [TBL] [Abstract][Full Text] [Related]
4. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma. Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456 [TBL] [Abstract][Full Text] [Related]
5. Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating. Guo X; Wu G; Wang H; Chen L J Pharm Sci; 2019 May; 108(5):1726-1735. PubMed ID: 30537472 [TBL] [Abstract][Full Text] [Related]
6. Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery. Zhao YZ; Lin Q; Wong HL; Shen XT; Yang W; Xu HL; Mao KL; Tian FR; Yang JJ; Xu J; Xiao J; Lu CT J Control Release; 2016 Feb; 224():112-125. PubMed ID: 26792571 [TBL] [Abstract][Full Text] [Related]
7. Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery. Kang MH; Yoo HJ; Kwon YH; Yoon HY; Lee SG; Kim SR; Yeom DW; Kang MJ; Choi YW Mol Pharm; 2015 Dec; 12(12):4200-13. PubMed ID: 26544061 [TBL] [Abstract][Full Text] [Related]
8. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB. Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553 [TBL] [Abstract][Full Text] [Related]
9. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462 [TBL] [Abstract][Full Text] [Related]
10. Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation. Kang MJ; Kim BG; Eum JY; Park SH; Choi SE; An JJ; Jang SH; Eum WS; Lee J; Lee MW; Kang K; Oh CH; Choi SY; Choi YW J Drug Target; 2011 Aug; 19(7):497-505. PubMed ID: 20738150 [TBL] [Abstract][Full Text] [Related]
11. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853 [TBL] [Abstract][Full Text] [Related]
12. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy. Wang ZQ; Liu K; Huo ZJ; Li XC; Wang M; Liu P; Pang B; Wang SJ J Nanobiotechnology; 2015 Oct; 13():63. PubMed ID: 26427800 [TBL] [Abstract][Full Text] [Related]
13. Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy. Chi Y; Zhu S; Wang C; Zhou L; Zhang L; Li Z; Dai Y J Drug Target; 2016; 24(3):224-32. PubMed ID: 26219518 [TBL] [Abstract][Full Text] [Related]
14. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361 [TBL] [Abstract][Full Text] [Related]
15. Glioma-Targeted Delivery of a Theranostic Liposome Integrated with Quantum Dots, Superparamagnetic Iron Oxide, and Cilengitide for Dual-Imaging Guiding Cancer Surgery. Xu HL; Yang JJ; ZhuGe DL; Lin MT; Zhu QY; Jin BH; Tong MQ; Shen BX; Xiao J; Zhao YZ Adv Healthc Mater; 2018 May; 7(9):e1701130. PubMed ID: 29350498 [TBL] [Abstract][Full Text] [Related]
16. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528 [TBL] [Abstract][Full Text] [Related]
17. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
18. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419 [TBL] [Abstract][Full Text] [Related]
19. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery. Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928 [TBL] [Abstract][Full Text] [Related]